Advanced search
Publication Cover
Journal of Microencapsulation
Micro and Nano Carriers
Volume 38, 2021 - Issue 6
Submit an article Journal homepage
264
Views
7
CrossRef citations to date
0
Altmetric
Original Articles

Anti-inflammatory cytokine IL10 loaded cRGD liposomes for the targeted treatment of atherosclerosis

Jianchao Lia Department of Cardiopulmonary Bypass, Henan Provincial People’s Hospital, People’s Hospital of Zhengzhou University, Central China Fuwai Hospital, Central China Fuwai Hospital of Zhengzhou University, Zhengzhou, ChinaView further author information
,
Fuyan Dingb Department of Cardiovascular Surgery, Henan Provincial People’s Hospital, People’s Hospital of Zhengzhou University, Central China Fuwai Hospital, Central China Fuwai Hospital of Zhengzhou University, Zhengzhou, ChinaView further author information
,
Xiaoliang Qiana Department of Cardiopulmonary Bypass, Henan Provincial People’s Hospital, People’s Hospital of Zhengzhou University, Central China Fuwai Hospital, Central China Fuwai Hospital of Zhengzhou University, Zhengzhou, ChinaView further author information
,
Junjie Sunb Department of Cardiovascular Surgery, Henan Provincial People’s Hospital, People’s Hospital of Zhengzhou University, Central China Fuwai Hospital, Central China Fuwai Hospital of Zhengzhou University, Zhengzhou, ChinaView further author information
,
Zhenwei Geb Department of Cardiovascular Surgery, Henan Provincial People’s Hospital, People’s Hospital of Zhengzhou University, Central China Fuwai Hospital, Central China Fuwai Hospital of Zhengzhou University, Zhengzhou, ChinaView further author information
,
Leiyi Yanga Department of Cardiopulmonary Bypass, Henan Provincial People’s Hospital, People’s Hospital of Zhengzhou University, Central China Fuwai Hospital, Central China Fuwai Hospital of Zhengzhou University, Zhengzhou, ChinaView further author information
&
Zhaoyun Chengb Department of Cardiovascular Surgery, Henan Provincial People’s Hospital, People’s Hospital of Zhengzhou University, Central China Fuwai Hospital, Central China Fuwai Hospital of Zhengzhou University, Zhengzhou, ChinaCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0001-5047-7948View further author information
ORCID Icon show all
Pages 357-364 | Received 21 May 2020, Accepted 25 Sep 2020, Published online: 12 Jul 2021

References

  • Almer, G., et al. 2013. Interleukin-10: an anti-inflammatory marker to target atherosclerotic lesions via PEGylated liposomes. Molecular pharmaceutics, 10 (1), 175–186.
  • Ambesh, P., et al. 2017. Nanomedicine in coronary artery disease. Indian heart journal, 69 (2), 244–251.
  • Asadullah, K., Sterry, W., and Volk, H.D., 2003. Interleukin-10 therapy-review of a new approach. Pharmacological reviews, 55 (2), 241–269.
  • Bozzuto, G. and Molinari, A., 2015. Liposomes as nanomedical devices. International journal of nanomedicine, 10, 975–999.
  • Buttar, H.S., Li, T., and Ravi, N., 2005. Prevention of cardiovascular diseases: role of exercise, dietary interventions, obesity and smoking cessation. Experimental and clinical cardiology, 10 (4), 229–249.
  • Caldorera-Moore, M., et al. 2010. Designer nanoparticles: incorporating size, shape and triggered release into nanoscale drug carriers. Expert opinion on drug delivery, 7 (4), 479–495.
  • Chen, Y., et al. 2014. Inflammatory stress induces statin resistance by disrupting 3-hydroxy-3-methylglutaryl-CoA reductase feedback regulation. Arteriosclerosis, thrombosis, and vascular biology, 34 (2), 365–376.
  • Dwivedi, P., et al. 2019. Engineered multifunctional biodegradable hybrid microparticles for paclitaxel delivery in cancer therapy. Materials science & engineering. C, materials for biological applications, 102, 113–123.
  • Fleg, J.L., et al. 2012. Detection of high-risk atherosclerotic plaque: report of the NHLBI working group on current status and future directions. JACC: cardiovascular imaging, 5 (9), 941–955.
  • Gupta, P.K., et al. 2014. Exploitation of lectinized lipo-polymerosome encapsulated amphotericin B to target macrophages for effective chemotherapy of visceral leishmaniasis. Bioconjugate chemistry, 25 (6), 1091–1102.
  • Katsuki, S., et al. 2017. Anti-inflammatory nanomedicine for cardiovascular disease. Frontiers in cardiovascular medicine, 4, 87–87.
  • Khandelwal, K., et al. 2015. Improved oral bioavailability of novel antithrombotic S002-333 via chitosan coated liposomes: a pharmacokinetic assessment. RSC advances, 5 (49), 39168–39176.
  • Kim, M., et al. 2020. Targeted delivery of anti-inflammatory cytokine by nanocarrier reduces atherosclerosis in Apo E-/- mice. Biomaterials, 226, 119550.
  • Kotyla, P., 2010. The role of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors (statins) in modern rheumatology. Therapeutic advances in musculoskeletal disease, 2 (5), 257–269.
  • Li, M.-C. and He, S.-H., 2004. IL-10 and its related cytokines for treatment of inflammatory bowel disease. World journal of gastroenterology, 10 (5), 620–625.
  • Mosser, D.M. and Zhang, X., 2008. Interleukin-10: new perspectives on an old cytokine. Immunological reviews, 226, 205–218.
  • Nakhlband, A., et al. 2018. Combating atherosclerosis with targeted nanomedicines: recent advances and future prospective. Bioimpacts, 8 (1), 59–75.
  • Rafieian-Kopaei, M., et al. 2014. Atherosclerosis: process, indicators, risk factors and new hopes. International journal of preventive medicine, 5 (8), 927–946.
  • Sakai, K., et al. 2018. Myeloid HMG-CoA (3-hydroxy-3-methylglutaryl-coenzyme A) reductase determines atherosclerosis by modulating migration of macrophages. Arteriosclerosis, thrombosis, and vascular biology, 38 (11), 2590–2600.
  • Sharma, K., Kumar, K., and Mishra, N., 2016. Nanoparticulate carrier system: a novel treatment approach for hyperlipidemia. Drug delivery, 23 (3), 684–699.
  • Zhaorigetu, S., et al. 2014. Delivery of negatively charged liposomes into the atherosclerotic plaque of apolipoprotein E-deficient mouse aortic tissue. Journal of liposome research, 24 (3), 182–190.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.